U.S. Continuous Glucose Monitoring Systems (CGMS) Market by Component (Insulin Pumps, Transmitters & Receivers, and Sensors), Age Group (Adult and Children), Distribution Channel (Retail Pharmacy and Online Pharmacy), and End User (Hospitals, Clinics, Homecare Diagnostics, and Others): Opportunity Analysis and Industry Forecast, 2019–2026

Pages: NA
Oct 2020 | 890 Views
Author(s) : NA
Tables: NA
Charts: NA


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the U.s. Continuous Glucose Monitoring Systems (cgms) Market

Request Now !

Continuous Glucose Monitoring System (CGMS) is an advanced sensor technology used to track glucose level without pricking fingers. It is more effective & accessible for patients with type 2 diabetes (T2D). In it the glucose levels are taken from interstitial fluid. The system takes glucose measurements at regular intervals, 24 hours a day, and generates glucose direction & rate of change. The system involves reusable transmitters that provide real-time reading of glucose monitoring. It can help reduce the risk of hypoglycemia & hyperglycemia, whether users are on pump therapy or insulin injections. According to Centers for Disease Control and Prevention (CDC) report, in 2017, around 30.3 million people suffered from diabetes in the U.S. In September 2017, the FDA approved first CGMS that does not require fingerstick measurement calibration. Components of continuous glucose monitoring system include insulin pumps, transmitters & receivers, and sensors. The adult population makes more use of the system compared to children as the number of diabetic patients is more for adults.


Rise in adoption of the system, increase in prevalence of diabetes across the U.S., and rise in awareness among people are the key factors that is expected to drive the U.S. continuous glucose monitoring systems market during the forecast period. In addition, surge in need for hypoglycemic & hyperglycemic diagnosis and rise in demand for glucose level testing instantly is expected to boost the market in the coming years. Moreover, rise in opportunities in the U.S. with the surge in need for R & D by the key players is also expected to boost the growth of the market. However, expensive systems and stringent regulatory policies are the major restraints that are anticipated to hamper the growth of the market during the forecast period. In addition, increase in undiagnosed patient population and rise in product awareness is expected to provide numerous opportunities for the market in the coming years.

The market is segmented on the basis of component, age group, distribution channel, and end user. On the basis of component, it is categorized into insulin pumps, transmitters & receivers, and sensors. On the basis of age group, it is divided into adult and children. On the basis of distribution channel, it is segmented into retail pharmacy and online pharmacy. On the basis of end user, it is divided into hospitals, clinics, homecare diagnostics, and others.

Some of the major players operating in the U.S. continuous glucose monitoring systems (CGMS) market include Abbott Laboratories, Pfizer Inc., Baxter International Inc., Echo Therapeutics, Inc., Medtronic plc, F. Hoffmann-La Roche AG, Dexcom Inc., Animas Corporation, Novo Nordisk A/S, and GlySens Incorporated.


  • This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which assists to identify the prevailing U.S. continuous glucose monitoring systems (CGMS) market opportunities. 
  • An in-depth market analysis includes study of the market and is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate the U.S. plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the market is provided in the report.
  • The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026, in terms of value.
  • An extensive analysis of the market provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the U.S. continuous glucose monitoring systems (CGMS) market.


By Component

  • Insulin Pumps
  • Transmitters & Receivers
  • Sensors

By Age Group

  • Adult
  • Children

By Distribution Channel

  • Retail pharmacy
  • Online pharmacy

By End User

  • Hospitals 
  • Clinics
  • Homecare Diagnostics
  • Others


1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models


2.1. Key findings of the study
2.2. CXO Perspective


3.1. Market definition
3.2. Need for glucose monitoring systems

3.2.1. Diabetes–a pandemic Type 1 diabetes Type-2 diabetes Prediabetes and gestational diabetes mellitus (GDM) Gestational diabetes mellitus (GDM) Secondary diabetes U.S. healthcare expenditure on diabetes

3.3. Key Findings

3.3.1. Top investment pockets
3.3.2. Top winning strategies
3.3.3. Value Chain Analysis

3.4. Patent analysis

3.4.1. U.S. patent analysis, by market participant
3.4.2. Patent analysis, by year

3.5. Market Share Analysis, 2017 (Global)
3.6. FDA Government Regulations (21CFR820)

3.6.1. Objective and Scope of FDA 21CFR820

3.7. Reimbursement Scenario
3.8. Market dynamics

3.8.1. Drivers
3.8.2. Restraints
3.8.3. Opportunities
3.8.4. Impact analyses


4.1. Overview

4.1.1. Market size and forecast

4.2. Sensors

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Transmitters & Receivers

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Integrated Insulin pumps

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast


5.1. Overview

5.1.1. Market size and forecast

5.2. Adult Population (>14 years)

5.2.1. Market size and forecast

5.3. Children Population (≤14 years)

5.3.1. Market size and forecast


6.1. Overview

6.1.1. Market size and forecast

6.2. Diagnostic centers/clinics

6.2.1. Market size and forecast

6.3. ICUs

6.3.1. Market size and forecast

6.4. Home Healthcare

6.4.1. Market size and forecast


7.1. Abbott Laboratories

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. A. Menarini Diagnostics S.r.l.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio

7.3. DexCom, Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Product portfolio
7.3.4. Business performance
7.3.5. Key strategic moves and developments

7.4. Echo Therapeutics, Inc.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Key strategic moves and developments

7.5. F. Hoffmann-La Roche Ltd.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. GlySens Incorporated

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Key strategic moves and developments

7.7. Insulet Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Product portfolio
7.7.4. Business performance
7.7.5. Key strategic moves and developments

7.8. Johnson & Johnson

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments

7.9. Medtronic Plc.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. Senseonics Holdings, Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Start reading ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at










Purchase Full Report of
U.S. Continuous Glucose Monitoring Systems (CGMS) Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $8,995  $8,096
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts